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The complement (C) system is made up of some 30 distinct proteins that are present in
blood plasma and on cell membranes as precursor enzymes, effector molecules and control
proteins. The principal function of the C system is to defend the host against microbial infections.
The activation of C triggers a series of reactions that generate the so called membrane attack
complex (MAC) on the activating surface. MAC is a pore-like lesion that destabilizes the the
target cell membrane resulting in cell lysis. Two pathways have been distinguished by which the
complement system can become activated. Activation of the classical pathway is triggered by
immunoglobulins (IgG and IgM), while the activation of the alternative pathway is nonspecific
and is triggered directly by the target surface.
Activated complement may be cytotoxic also to the host cells. However, normal cells can
resist the cytolytic activity of complement by expressing several regulatory proteins on their cell
surface. On the cell membranes several inhibitor molecules have been described (C8bp, CD35,
CD46, CD55 and CD59). Two of these (C8bp and CD59 or protectin) have been demonstrated to
directly inhibit the formation of MAC. CD59 is a 18 - 24kDa glycoprotein that is anchored to
cell membranes via a glycophosphoinositol (GPI) moiety. Protectin is widely distributed on
human blood cells and on endothelial and epithelial cells of several organs. In addition to various
cell membranes phospholipid+ailed protectin has been found in amniotic fluid and in seminal
plasma, where it has been shown to be associated with extracellular organelles called
prostasomes. Soluble, lipid-free forms of protectin have been isolated from human urine and
produced in recombinant form but they have only a relatively weak complement lysis inhibiting
activity.
Because of its activities as an inflammation-inducing and cytolytic system, complement
can increase tissue damage in many disorders. It has been suggested that the activation of the
complement system may be involved in the development of tissue injury during myocardial
infarction. Another example of pathologic C activation is paroxysmal nocturnal haemoglobinuria
(PNH) where host blood cells become lysed by the autologous C system. PNH is a human disease
characterized by a deficiency of GPl-anchored glycoproteins. Because of its activities CD59 is a
candidate molecule for the treatment of PNH or in conditions where MAC causes tissue damage.
In the present study the physiology and function of protectin have been analyzed in
human breast milk. Milk is rich in fat droplets, milk fat globules (MFG), that are enveloped in a
plasma
MFG
membrane derived from the secretory cells of the mammary gland. The membranes of the
contain a variety
immunofluorescence and
expressed on human MFG
bands with apparent Mr:s
carcinoma cells and erythrocyte membranes. CD59M in breast milk was functionally active and
had a glycophospholipid-anchor as judged by its ability to incorporate into quinea pig
erythrocytes and inhibit their lysis by human complement. These results indicate that functionally
active protectin becomes enriched in milk fat globules and imply that secretion of GPl-anchored
molecules e.g. into cow milk could be exploited as a means to produce bioactive molecules that
need to be targeted into cell membranes.
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